Navigation Links
MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
Date:9/2/2009

MOUNTAIN VIEW, Calif., Sept. 2 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that it will participate in the following events in September:

    Thomas Weisel Partners Healthcare Conference 2009
    Friday, September 11, at 10:20 a.m. ET in Boston

    14th Congress of the International Headache Society
    September 10 to 13, in Philadelphia
    Late-Breaking oral platform presentation on Saturday, September 12, at
     7:35 a.m. ET
    Three posters can be viewed during the conference

    Webcast to discuss Phase 3 LEVADEX(TM) data presented in a late-breaking
     session at the 14th Congress of the International Headache Society
    Monday, September 14th at 7:15 a.m. ET

    Morgan Stanley Global Healthcare Conference
    Monday, September 14, at 1:00 p.m. ET in New York City

Live webcasts of the events on Friday, September 11 and Monday, September 14 will be available in the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for at least seven days following each presentation.

About MAP Pharmaceuticals

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalati
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Calif. (PRWEB) May 24, 2013 Western ... retained its status of “Full Accreditation” for the next ... Council on Education (COE). , “This is a magnificent ... our hard work and student outcomes,” said College of ... to express my appreciation to the faculty, staff, preceptors, ...
(Date:5/24/2013)... (HealthDay News) -- New research suggests a link ... with insomnia. Every additional hour someone with ... drop in the likelihood of moderate or high ... University of Pennsylvania. "We were surprised ... duration and suicide risk," study author, Linden Oliver, ...
(Date:5/24/2013)... GA (PRWEB) May 24, 2013 Started in ... held in Orlando. 2013 marks AMTC’s 31st anniversary. SHINE ... family, starting with supermodel Millie Lewis and her daughter, Carey ... top agents, managers, casting directors, and music professionals including the ... Arts and XP Media. They are kings of Hollywood and ...
(Date:5/24/2013)... The nation’s first trial of a ... da Vinci Surgical System concluded yesterday, Bernstein Liebhard LLP ... Court jury ruled in a 10-to-2 decision that Intuitive ... performed a da Vinci prostatectomy on a patient who ... alleged in their lawsuit that the da Vinci complications ...
(Date:5/24/2013)... Stoler believes that there is much to be learned ... That’s why he hosts “Building New York—New York ... that’s why he invited Robert Glazer, Chief Executive Officer ... specialty practice in the greater New York area, whose ... sub-specialists service communities throughout New York and New Jersey ...
Breaking Medicine News(10 mins):Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4
... speculated over the negative effects of environmental toxins for ... disrupt the normal growth and hormonal development of girls. ... zearalenone (ZEA) produced by the Fusarium fungus species, can ... to the female reproductive hormone estrogen, and are also ...
... embarking on an expanded major clinical trial involving the use ... if the combined treatment is more effective than radiation therapy ... clinical trial is part of a $9 million grant from ... study the effectiveness of gene therapy to treat prostate cancer. ...
... asks board member to seek restatement of Beth Israel ... & Wyoming director,Robert M. Melzer should apply the same ... traded companies to his role on the,board of CareGroup, ... according to labor group 1199 SEIU United,Healthcare Workers East. ...
... Health Company,(Amex: FHC ) today announced that ... its operating results for the first quarter of ... February 13, 2008. The Company plans,to report its ... day., Shareholders and other interested parties may ...
... Union asks board member to seek restatement of ... 6 Charles River Laboratories,International director Stephen Chubb ... River Laboratories and other publicly traded,companies to his ... organization of,Beth Israel Deaconess Medical Center (BIDMC), according ...
... Co-Founder Todd Rosengart Offers Lifesaving Tips in the Fight ... ... data released from,the Center for Disease Control indicates that deaths resulting ... such as obesity, high blood pressure and high cholesterol remain on,the ...
Cached Medicine News:Health News:New study suggests link between environmental toxins and early onset puberty in girls 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 3Health News:Genesee & Wyoming Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:The Female Health Company Schedules First Quarter Conference Call for February 13, 2008 2Health News:Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Vitals.com 'Goes Red' for American Heart Month 2Health News:Vitals.com 'Goes Red' for American Heart Month 3
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
... SEATTLE, Sept. 24 Cell Therapeutics, Inc. (CTI) (Nasdaq ... II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined ... esophageal cancer will be presented by Dr. Howard Safran in ... the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on ...
... September 23 As of today, 23 September,2009, the site will be ... solidarity and digital art. , For just 1 ... project, will be to save the life of a child! , ... of the project,OneDotOneLife which has two objectives. , ...
Cached Medicine Technology:OneDotOneLife.org - Saving the Lives of More Than 2 Million Children 2
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... AMS 700 Series is an advanced three-part inflatable ... abdomen, a pump placed in the scrotum and ... cavernosa. It closely simulates the look and performance ... innovative penile implant technology, the AMS 700 Series ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
Medicine Products: